CRP and experimental autoimmune encephalomyelitis: Moreover, an in vitro study demonstrated that human CRP directly contributes to adaptive immunity, with its native form specifically binding to human Jurkat T cells and to mouse naive CD4+ T cells, modulating their Th1 and Th2 responses and thus alleviating experimental autoimmune encephalomyelitis [116].